Dr. Kevin Fitzgerald, PhD.Chief Scientific Officer at EpsilogenSpeaker
Agenda Sessions
Chairperson's Remarks
, 14:10View SessionThe Therapeutic Potential of IgE and IgE-derived Antibodies
, 14:15View Session